Click to copy
Click to copy
Related topics

UniQure: 2Q Earnings Snapshot

July 29, 2019

AMSTERDAM (AP) _ UniQure NV (QURE) on Monday reported a loss of $31.4 million in its second quarter.

The Amsterdam-based company said it had a loss of 83 cents per share.

The results did not meet Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 75 cents per share.

The human gene therapy company posted revenue of $2.5 million in the period, surpassing Street forecasts. Five analysts surveyed by Zacks expected $1.5 million.

UniQure shares have more than doubled since the beginning of the year. The stock has more than doubled in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on QURE at https://www.zacks.com/ap/QURE

All contents © copyright 2019 The Associated Press. All rights reserved.